A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors

Clinical trial NCT04673942 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04673942
Sponsor: EpicentRx, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Cancer Neoplasms Sarcoma Sarcoma,Soft Tissue Chondrosarcoma

Start date: 2021-03-29
Primary completion: 2026-12-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.